![]() | BOS 2022: Balticum Organicum Syntheticum 2022 Radisson Blu Hotel Lietuva Vilnius, Lithuania, July 3-6, 2022 |
Conference website | https://boschem.eu/bos2022/ |
Submission link | https://easychair.org/conferences/?conf=bos2022 |
Submission deadline | April 17, 2022 |
The biennial Balticum Organicum Syntheticum conference is a chemistry conference held in the capitals of the Baltic States. The conference main aims are as follows:
- to convey the excitement of synthetic organic chemistry as practiced in industry and universities worldwide;
- to promote interactions between chemists of the Baltic with the other countries of the world in order to create links, collaborations, common research projects in both, academic and industrial setting;
- showcase the historical significance, architecture, and beauty of the Baltic States. With the participation of many Estonian, Latvian and Lithuanian chemists, you will also become aware of the history, culture, language, and social framework of Baltic States.
The programme and format of BOS conferences is composed of two primary formats: plenary lectures by a distinguished roster of Baltic and international speakers, and poster sessions held in a congenial atmosphere to stimulate discussion. We aim for a balanced program of academic and industrial speakers presenting fundamental and practical aspects of organic synthesis.
Submission Guidelines
BOS Conference offers an opportunity to deliver presentations in either a poster or an oral format therefore authors are invited to submit abstracts until April 1, 2022. Deadline is extended until April 17, 2022.
GENERAL GUIDELINES:
- All abstracts must be submitted via EasyCahir platform.
- Authors will receive an automatic confirmation once an abstract is submitted.
- All abstracts will be reviewed by the Scientific Committee. Confirmation of the status/form of the presentation will be sent once the review process is complete but no later than April 15, 2022. Deadline is extended until May 2, 2022
- Authors are asked to state their format preference as part of their online abstract submission however the Scientific Committee reserves the right to decide on the final type of presentation.
- After the abstract is accepted, the presenting author is expected to register and pay the fee until May 10, 2022 otherwise the Scientific Committee reserves the right to withdraw the abstract from the Abstract Book. It is also expected that the presenting author would attend the BOS Conference and do a presentation at the event.
- There is no limitation for the number of abstracts that one author can submit.
- If an abstract submission confirmation email or an abstract status notification email is not received, we advice to check a spam folder first. If emails are not found there, we ask authors to contact BOS Secretariat at registration@seventips.lt.
GUIDELINES FOR SUBMISSION:
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. We recommend that a native English speaker should edit each abstract before submission.
- Please include full name (not initials) of each author so that an accurate index could be produced. If the author is on more than one abstract, please make sure that the name and affiliation is identical in each abstract, so that all abstracts could be indexed to the same name.
- Your abstract should be less than one page (A5-paper) in length.
- All abstracts must be presented in .doc / .docx format by filling a template which can be downloaded from EasyChair platfrom.
- After submission abstract content and other details can be modified until April 17, 2022. Please login to EasyChair to update your abstract.
Organizing Committee
- Prof. Eugenijus Butkus, Vilnius University, Lithuania
- Dr. Jaan Pesti, EnginZyme AB, USA
- Dr. John Duncia, Bristol-Myers Squibb Co., Princeton, USA
Invited Speakers
- Christophe Allais, Pfizer Inc, USA
- Olivier Baudoin, University of Basel, Switzerland
- Diane E. Carrera, Bolt Biotherapeutics Redwood City California, USA
- Olafs Daugulis, Department of Chemistry, University of Houston, USA
- Patrick S. Fier, Merck & Co., Inc., USA
- Vilius Franckevičius, Department of Chemistry at Lancaster University, United Kingdom
- Karl Anker Jørgensen, Department of Chemistry, Aarhus University, Denmark
- Romas Kudirka, Bolt Biotherapautics, USA
- Sébastien Lemaire, Johnson & Johnson, Shanghai, China
- Stefan Matile, University of Geneva, Geneva, Switzerland
- Andres Merits, Institute of T echnology, University of Tartu, Estonia
- Bill Morandi, ETH Zürich, Switzerland
- Martin Oestreich, Technische Universität Berlin, Germany
- Addy Pross, Department of Chemistry Ben Gurion University, Israel
- Tobias Ritter, Max-Planck-Institut für Kohlenforschung, Germany
- Antonia F. Stepan, F. Hoffmann-La Roche Ltd Neuroscience and Rare Disease Medicinal Chemistry Rhein, Germany
- Tehshik P. Yoon, University of Wisconsin – Madison, USA
Contact
All questions about submissions should be emailed to registration@seventips.lt